Members discuss extending MC12 TRIPS Decision to COVID-19 diagnostics and therapeutics

WTO members advanced discussions on whether to extend the TRIPS Decision adopted in June at the 12th WTO Ministerial Conference to COVID-19 diagnostics and therapeutics. At a meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on 12-13 October, the chair of the Council, Ambassador Dr Lansana Gberie of Sierra Leone, urged delegations to submit text-based proposals indicating how they envisage an agreed outcome on this issue with a view to helping members reach a decision by the prescribed 17 December deadline.

All copyrights for this article are reserved to WTO news